Cytosorbents Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 9.45 million compared to USD 8.69 million a year ago. Net loss was USD 7.33 million compared to USD 8.97 million a year ago.

Basic loss per share from continuing operations was USD 0.17 compared to USD 0.21 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.21 a year ago.